secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001668397-23-000040
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace Q2 revenue $469.4M (+27% YoY), EPS $2.35 (+62%); raises FY 2023 guidance
--------------------------------------------------------------------------------

- Revenue $469.4M (+27.4% YoY), net income $75.6M (+62.5%), diluted EPS $2.35.
- Backlog $2.8B (+18.7%); net new business awards $502.3M (+8.3%).
- FY 2023 guidance raised: revenue $1.765B-$1.795B, EPS $8.60-$8.97.
- Operating cash flow $120.4M, free cash flow $110.3M in H1; $465M cash, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000166839723000040/0001668397-23-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000166839723000040/medp-20230724.htm
  HTML page:      https://secwatch.observer/filing/0001668397-23-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer